Summary

The Middle East and Africa blood glucose monitor market is an important region within the global healthcare landscape, owing to a convergence of factors influencing diabetes management in the region. This market represents a diversified blend of innovative technology, growing healthcare infrastructures, and a compelling need for effective solutions to address the region's rising diabetes prevalence. Diabetes cases are on the rise in the Middle East & Africa region, owing to lifestyle changes, urbanisation, and genetic predisposition. The rising prevalence of diabetes feeds the demand for better blood glucose monitoring equipment. In emerging countries of Middle East & Africa, the prevalence of lifestyle disorders such as diabetes is rising, driving up demand for blood glucose monitoring equipment. Increased awareness about healthcare facilities and preventive care is also contributing to market growth. The number of patients who use self-monitoring blood glucose (SMBG) has grown. Because of the high costs associated with continuous glucose monitoring (CGM), glucometer self-monitoring is more acceptable in the Middle East and Africa region. These devices aid in the early diagnosis of hypo and hyperglycemia situations, which drives the glucose monitoring industry. The Middle East & Africa region has a diverse healthcare infrastructure, ranging from highly developed urban institutions to rural areas with minimal access. This variety affects the types of blood glucose monitors used, necessitating devices that can be used in a variety of healthcare settings. Chronic diseases, including diabetes, are common in the Middle East & Africa region. This prevalence drives the demand for blood glucose monitoring devices designed to effectively manage chronic illnesses, driving innovation and the adoption of cutting-edge technologies. The affordability and accessibility of devices are influenced by economic variables. Blood glucose monitors that are designed to handle economic constraints while retaining quality and usefulness are becoming increasingly important for widespread adoption.

According to the research report, "Middle East & Africa Blood Glucose Monitoring Devices Market Outlook, 2028," published by Bonafide Research, the Middle East & Africa Blood Glucose Monitoring Devices market is anticipated to grow at a 10% CAGR by 2023–28. Blood glucose monitoring in Middle East & Africa has been transformed by technological integration with smart glucose metres and smartphone applications. These gadgets connect to cellphones, allowing users to effortlessly track and analyse their glucose readings. Mobile apps include capabilities such as data storage, trend analysis, and real-time monitoring, which improve user engagement and adherence to monitoring regimens. Wearable technology has produced tremendous advances in Middle East & Africa blood glucose monitoring. Continuous glucose monitoring patches or smartwatches with embedded sensors, for example, provide discreet and continuous monitoring. This advancement is in line with the region's growing interest in wearable technology, enhancing user ease and fostering continuous monitoring without interfering with daily activities. Diabetes management in Middle East & Africa has been changed by the combination of blood glucose monitors with telehealth systems. Remote patient monitoring, consultations, and data exchange are made possible by these gadgets, allowing healthcare providers to provide guidance and interventions even in remote or disadvantaged places. This innovation was especially important during the COVID-19 epidemic, hastening the implementation of telehealth solutions throughout the region. Cloud-based data management technologies have made glucose data more accessible in Middle East & Africa. Blood glucose monitors that sync data with cloud platforms enable secure storage, simple access to past readings, and information sharing with healthcare professionals, thereby fostering collaborative and data-driven care approaches.

Based on country report includes, United Arab Emirates, Saudi Arabia and South Africa. Among them United Arab Emirates is anticipated to play crucial role in development of Middle East & Africa blood glucose monitor market.

The United Arab Emirates features cutting-edge healthcare facilities and a strong emphasis on medical tourism. This infrastructure makes it possible to provide cutting-edge technologies, such as blood glucose monitoring, to both residents and tourists. The multinational community of the United Arab Emirates provides a one-of-a-kind market landscape. Blood glucose monitoring systems can be tailored to different cultural preferences, languages, and healthcare practices, ensuring market inclusion and relevance. The United Arab Emirates, strategically placed in the Middle East, serves as a regional hub for disseminating healthcare breakthroughs. Blood glucose monitoring technological advancements introduced in the United Arab Emirates typically spread to adjacent countries, influencing the wider regional market. Diabetes is a rather common ailment in the United Arab Emirates, affecting approximately 15% of the adult population (aged 18 and above). This is due to a variety of variables, such as urbanisation, lifestyle changes, and genetic predisposition. Diabetes research and innovation are encouraged in the United Arab Emirates, with many universities and research institutions doing investigations on new medicines, technology, and prevention measures. The emphasis on patient empowerment and tailored care experiences is driving demand for user-friendly and accurate blood glucose monitoring devices. This is consistent with the United Arab Emirates commitment to providing patient-centred healthcare solutions. Diabetes management is part of the United Arab Emirates focus on regenerative medicine and futuristic healthcare solutions. Current diabetes research in regenerative therapies has the potential to change treatment techniques by complementing blood glucose monitoring.

Based on product market is segmented into self-monitoring devices and continuous blood glucose monitoring devices. Continuous blood glucose monitoring devices is expected to grow at rapid pace in Middle East & Africa blood glucose monitor market.

Diabetes prevalence has risen significantly in the Middle East & Africa region in recent years. Diabetes has become a serious health concern in this region as a result of lifestyle changes, urbanisation, and genetic predispositions. Continuous blood glucose monitoring devices take a proactive approach to diabetes treatment by delivering real-time data, allowing for better diabetes control and management. Continuous blood glucose monitoring devices have advanced significantly in terms of technology. These gadgets now have better accuracy, convenience, and connectivity functions. In the Middle East & Africa region, where access to healthcare services may be limited in some locations, the simplicity of continuous monitoring provides an appealing alternative for diabetics. Many countries in the Middle East & Africa region are investing in their healthcare infrastructure, including advancements in medical technology. This investment creates opportunities for the introduction and adoption of innovative medical devices such as continuous blood glucose monitors within hospitals, clinics, and healthcare facilities.

Based on end user segment market includes, hospitals, home care, and diagnostic centers. Home care end user segment is expected to play pivotal role in development of Middle East & Africa blood glucose monitor market.

There is an increasing trend towards home-based healthcare solutions in the Middle East & Africa region. People prefer to manage their health issues, such as diabetes, from the comfort of their own homes. Blood glucose monitors developed for home use provide patients with convenience and autonomy by allowing them to monitor their glucose levels on a regular basis without the requirement for frequent hospital visits. The Middle East & Africa region's ageing population and the prevalence of chronic diseases such as diabetes are on the rise. Home care blood glucose monitors meet the needs of older people who may find it difficult to visit healthcare institutions on a regular basis. They provide a handy alternative for at-home continuous monitoring and management of chronic illnesses. Home blood glucose monitors are becoming more inexpensive and cost-effective, making them more widely available in the Middle East & Africa region. As affordability increases, the adoption of these devices for home use is expected to rise.

Companies Covered in this report:
F. Hoffmann-La Roche AG, Abbott Laboratories, Nipro Corporation, B. Braun Melsungen AG, Medtronic plc, DexCom, Inc, Bionime Corporation, Sanofi S.A.

Considered in this report:

• Geography: Middle East & Africa
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Middle East & Africa Blood Glucose Monitor market Outlook with its value and forecast along with its segments
• Country-wise Blood Glucose Monitor market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United Arab Emirates
• Saudi Arabia
• South Africa

By Product

• Self-monitoring Devices
• Continuous Blood Glucose Monitoring Devices

By End User

• Hospitals
• Home Care
• Diagnostic Centers

By Indication

• Diabetes
• Pregnancy
• Cardiovascular Disorders & Hypertension
• Cancer
• Respiratory Diseases
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Blood Glucose Monitor industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.





***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents